Results 21 to 30 of about 180,603 (167)
PLoS ONE, 2019 ObjectivesTo investigate the prevalence, clinical characteristics, and prognosis of thrombocytopenia (TP) in Chinese patients with systemic lupus erythematosus (SLE).MethodsThe study was conducted based on the Chinese SLE Treatment and Research group ...
N Jiang +13 more
doaj +1 more source
Thrombocytopenia in pregnancy: is this immune thrombocytopenia or…? [PDF]
Hematology, 2012 Abstract Thrombocytopenia is a common finding in pregnancy. Establishing the diagnosis of immune thrombocytopenia (ITP) in a pregnant patient is similar to doing so in a nonpregnant patient, except that the evaluation must specifically rule out other disorders of pregnancy associated with low platelet counts that present different risks ...
openaire +2 more sources
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023 Thrombocytopenia is a rare but serious complication of the intravenous glycoprotein IIb/IIIa (GPIIb/IIIa; integrin αIIbβ3) receptor inhibitors (GPIs), abciximab, eptifibatide, and tirofiban. The thrombocytopenia ranges from mild (50 000–100 000 platelets/
Sem A. O. F. Rikken +4 more
doaj +1 more source
Thrombocytopenia in pregnancy [PDF]
Postgraduate Medical Journal, 1992 Thrombocytopenia is defined as a platelet count of less than 150 x 109/l. Normal pregnancy is generally thought not to affect the platelet count,' but it has been suggested that the normal range is lower in pregnancy, and that the count falls in the third trimester.2`4 This review concentrates on causes of thrombocytopenia with particular reference to ...
openaire +2 more sources
Treatment of drug-induced immune thrombocytopenias
Haematologica, 2022 Several therapeutic agents can cause thrombocytopenia by either immune-mediated or non-immune-mediated mechanisms. Non-immune-mediated thrombocytopenia is due to direct toxicity of drug molecules to platelets or megakaryocytes.
Irene Marini +3 more
doaj +1 more source
Thrombocytopenia in pregnancy [PDF]
Hematology, 2017 Abstract Thrombocytopenia develops in 5% to 10% of women during pregnancy or in the immediate postpartum period. A low platelet count is often an incidental feature, but it might also provide a biomarker of a coexisting systemic or gestational disorder and a potential reason for a maternal intervention or treatment that might pose harm ...
Douglas B. Cines, Lisa D. Levine
openaire +4 more sources
Pattern Analysis of Thrombocytopenia in Dengue versus Non-Dengue Patients [PDF]
National Journal of Laboratory Medicine, 2018 Introduction: Dengue fever is one of the most prevalent and fastest spreading mosquito-borne arboviral infection occurring in tropical and sub-tropical regions around the world and leads to explosive outbreaks in urban areas influenced strongly by ...
Smitha Bhaskar +6 more
doaj +1 more source
Thrombocytopenia as a Clinical Biomarker of Retinopathy of Prematurity
Folia Medica Indonesiana, 2023 Highlights: • This is the first systematic review investigating thrombocytopenia and its association with retinopathy of prematurity. • Thrombocytopenia can be a useful clinical biomarker in retinopathy of prematurity screening, considering the quick,
I Wayan Eka Sutyawan +4 more
doaj +1 more source
Prognostic value of thrombocytopenia during hospitalizations in intracerebral hemorrhage patients
Frontiers in NeurologyBackgroundThe thrombocytopenia influences prognoses of critically ill patients. There are few studies exploring the prognostic value of thrombocytopenia among ICH patients.
Hao Feng +4 more
doaj +1 more source